Medindia

X

Axolotl Biologix to Attend the National Indian Health Board's 33rd Annual Consumer Conference and 2016 National Tribal Health Conference

Tuesday, September 13, 2016 Indian Health News J E 4
Advertisement

PHOENIX, Sept. 13, 2016 /PRNewswire/ -- Axolotl Biologix, Inc., a biologics company that focuses on human tissue research and technology to enhance regenerative medicine, announced today that it will be attending the NIHB 33rd Annual Consumer Conference and 2016 National Tribal Health Conference as an exhibitor.  The conference will be held September 19-22 at Talking Stick Resort in Scottsdale, AZ. 

Logo - http://photos.prnewswire.com/prnh/20160912/406569LOGO

About Axolotl Biologix, Inc.

Axolotl Biologix, Inc. is a biologics company that develops and manufactures human tissue regenerative medicine products for orthopedic, wound care, podiatric, and cosmetic conditions.  The Company's lead product is its AxoBioFluid™, which is an amniotic allograft cryopreserved liquid that advances soft tissue repair, replacement, and reconstruction. The Company's vision is to be an innovative leader in regenerative medicine through research, technology, and clinical application.  For more information, please visit Axolotl Biologix' website at www.axobio.com.

Media Contact: Bob Maguire Email 602-354-3081

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/axolotl-biologix-to-attend-the-national-indian-health-boards-33rd-annual-consumer-conference-and-2016-national-tribal-health-conference-300326352.html

SOURCE Axolotl Biologix, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Women's Health Conversations (WHC) and Magee-Women...
S
Embracing Creativity Triggered by Brain Cancer: A...